Literature DB >> 26476733

Clinical, immunologic, and genetic characteristics of RAG mutations in 15 Chinese patients with SCID and Omenn syndrome.

Xiaoming Bai1, Jing Liu1, Zhiyong Zhang2, Chaohong Liu1, Yongjie Zhang1, Wenjing Tang1, Rongxin Dai1, Junfeng Wu2, Xuemei Tang2, Yu Zhang2, Yuan Ding2, Liping Jiang1, Xiaodong Zhao3,4,5.   

Abstract

Mutations in Recombination Activating Genes (RAG1 and RAG2) are common genetic causes of severe combined immunodeficiency (SCID) and Omenn syndrome (OS). The clinical, immunologic, and genetic characteristics of RAG mutations in Chinese patients with SCID or OS have not been studied in detail. In this research, 22 RAG mutations were identified in 15 Chinese patients, including 10 novel mutations in RAG1 (R108X, M630T, E510X, S666P, E669K, C730Y, A857V, K847E, L922PfsX7, and L1025FfsX39) and 4 in RAG2 (R73C, I427GfsX12, P432L, and 311insL). L1025FfsX39 is a potential RAG1 hot-spot mutation in the Chinese population. The distribution of RAG1 mutations rather than mutation type seemed to differ between SCID and OS patients. The thymic output of T lymphocytes, TCR rearrangement, and T cell proliferation were severely impaired in RAG mutant patients. These findings will contribute to the early diagnosis and treatment of SCID and OS to a certain extent.

Entities:  

Keywords:  Mutation; Omenn syndrome; Recombination Activating Gene 1; Recombination Activating Gene 2; Severe combined immunodeficiency

Mesh:

Substances:

Year:  2016        PMID: 26476733     DOI: 10.1007/s12026-015-8723-4

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   4.505


  30 in total

1.  Molecular diagnosis of severe combined immunodeficiency--identification of IL2RG, JAK3, IL7R, DCLRE1C, RAG1, and RAG2 mutations in a cohort of Chinese and Southeast Asian children.

Authors:  Pamela P W Lee; Koon-Wing Chan; Tong-Xin Chen; Li-Ping Jiang; Xiao-Chuan Wang; Hua-Song Zeng; Xiang-Yuan Chen; Woei-Kang Liew; Jing Chen; Kit-Man Chu; Lee-Lee Chan; Lynette Shek; Anselm C W Lee; Hsin-Hui Yu; Qiang Li; Chen-Guang Xu; Geraldine Sultan-Ugdoracion; Zarina Abdul Latiff; Amir Hamzah Abdul Latiff; Orathai Jirapongsananuruk; Marco H K Ho; Tsz-Leung Lee; Xi-Qiang Yang; Yu-Lung Lau
Journal:  J Clin Immunol       Date:  2010-12-24       Impact factor: 8.317

2.  RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination.

Authors:  M A Oettinger; D G Schatz; C Gorka; D Baltimore
Journal:  Science       Date:  1990-06-22       Impact factor: 47.728

3.  Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome.

Authors:  B Corneo; D Moshous; T Güngör; N Wulffraat; P Philippet; F L Le Deist; A Fischer; J P de Villartay
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

4.  Crystal structure of the V(D)J recombinase RAG1-RAG2.

Authors:  Min-Sung Kim; Mikalai Lapkouski; Wei Yang; Martin Gellert
Journal:  Nature       Date:  2015-02-18       Impact factor: 49.962

5.  T-cell receptor diversity is selectively skewed in T-cell populations of patients with Wiskott-Aldrich syndrome.

Authors:  Junfeng Wu; Dawei Liu; Wenwei Tu; Wenxia Song; Xiaodong Zhao
Journal:  J Allergy Clin Immunol       Date:  2014-08-01       Impact factor: 10.793

Review 6.  Severe combined immunodeficiency--an update.

Authors:  Emilia Cirillo; Giuliana Giardino; Vera Gallo; Roberta D'Assante; Fiorentino Grasso; Roberta Romano; Cristina Di Lillo; Giovanni Galasso; Claudio Pignata
Journal:  Ann N Y Acad Sci       Date:  2015-07-31       Impact factor: 5.691

7.  Analysis of mutations from SCID and Omenn syndrome patients reveals the central role of the Rag2 PHD domain in regulating V(D)J recombination.

Authors:  Chrystelle Couëdel; Christopher Roman; Alison Jones; Paolo Vezzoni; Anna Villa; Patricia Cortes
Journal:  J Clin Invest       Date:  2010-03-15       Impact factor: 14.808

8.  Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR.

Authors:  Stephan Borte; Ulrika von Döbeln; Anders Fasth; Ning Wang; Magdalena Janzi; Jacek Winiarski; Ulrich Sack; Qiang Pan-Hammarström; Michael Borte; Lennart Hammarström
Journal:  Blood       Date:  2011-11-30       Impact factor: 22.113

9.  Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.

Authors:  Hanna IJspeert; Gertjan J Driessen; Michael J Moorhouse; Nico G Hartwig; Beata Wolska-Kusnierz; Krzysztof Kalwak; Anna Pituch-Noworolska; Irina Kondratenko; Joris M van Montfrans; Ester Mejstrikova; Arjan C Lankester; Anton W Langerak; Dik C van Gent; Andrew P Stubbs; Jacques J M van Dongen; Mirjam van der Burg
Journal:  J Allergy Clin Immunol       Date:  2014-01-11       Impact factor: 10.793

10.  Partial V(D)J recombination activity leads to Omenn syndrome.

Authors:  A Villa; S Santagata; F Bozzi; S Giliani; A Frattini; L Imberti; L B Gatta; H D Ochs; K Schwarz; L D Notarangelo; P Vezzoni; E Spanopoulou
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

View more
  6 in total

Review 1.  [Red, scaly baby: a pediatric dermatological emergency : Clinical and differential diagnoses of neonatal erythroderma].

Authors:  H Ott; J Grothaus
Journal:  Hautarzt       Date:  2017-10       Impact factor: 0.751

2.  In vitro T lymphocyte proliferation by carboxyfluorescein diacetate succinimidyl ester method is helpful in diagnosing and managing primary immunodeficiencies.

Authors:  Elif Azarsiz; Neslihan Karaca; Birgul Ergun; Mehmet Durmuscan; Necil Kutukculer; Guzide Aksu
Journal:  J Clin Lab Anal       Date:  2017-04-06       Impact factor: 2.352

Review 3.  Autoimmunity in Primary Immunodeficiencies (PID).

Authors:  Grace T Padron; Vivian P Hernandez-Trujillo
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-01       Impact factor: 8.667

4.  Phenotypical heterogeneity in RAG-deficient patients from a highly consanguineous population.

Authors:  S S Meshaal; R E El Hawary; D S Abd Elaziz; A Eldash; R Alkady; S Lotfy; A A Mauracher; L Opitz; J Pachlopnik Schmid; M van der Burg; J Chou; N M Galal; J A Boutros; R Geha; A M Elmarsafy
Journal:  Clin Exp Immunol       Date:  2018-11-04       Impact factor: 4.330

5.  A Novel RAG1 Mutation in a Compound Heterozygous Status in a Child With Omenn Syndrome.

Authors:  Juan Shen; Li Jiang; Yifang Gao; Rongqiong Ou; Sifei Yu; Binyan Yang; Changyou Wu; Weiping Tan
Journal:  Front Genet       Date:  2019-10-02       Impact factor: 4.599

6.  Targeted high-throughput sequencing technique for the molecular diagnosis of primary immunodeficiency disorders.

Authors:  Zuo Hua Chi; Wei Wei; Ding Fang Bu; Huan Huan Li; Fei Ding; Ping Zhu
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.